SMS Pharmaceuticals' Bachupally facility Unit II successfully completes USFDA inspection

Image
Capital Market
Last Updated : Nov 20 2017 | 3:28 PM IST

Receives Zero Form 483 observations

SMS Pharmaceuticals has successfully completed, its Fifth US Food and Drug Administration (USFDA) inspection for its Manufacturing facility - Unit-II, located at Plot No.24 & 24B and 36 & 37, S.V. Co-operative Industrial Estate, Bachupally, Ranga Reddy District, Hyderabad-500 090, Telangana, India.

No Form 483 observations were issued during the inspection.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

More From This Section

First Published: Nov 20 2017 | 11:31 AM IST

Next Story